GT Biopharma, Inc. (GTBP) › EPS (Diluted)GT Biopharma, Inc. (GTBP) — EPS (Diluted)Annual figures by period end, from SEC filings.2015-12-31: $-8.962016-12-31: $119.912017-12-31: $-8.602018-12-31: $-5.162022-12-31: $-19.662023-12-31: $-5.642024-12-31: $-6.942025-12-31: $-6.68$-6.682015-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-6.68—2026-03-02From 2025-01-012024-12-31$-6.94—2026-03-02From 2024-01-012023-12-31$-5.64—2025-02-21From 2023-01-012022-12-31$-19.66—2024-03-26From 2022-01-012018-12-31$-5.16—2019-03-29From 2018-01-012017-12-31$-8.60-107.2%2019-03-29From 2017-01-012016-12-31$119.91—2018-03-01From 2016-01-012015-12-31$-8.96—2018-02-28From 2015-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)